Search

Surgical Implantation of Revakinagene Taroretcel-lwey

Charles C. Wykoff, MD PhD

Show Description +

Charles C. Wykoff, MD, PhD, performs one of the first commercial procedures using encapsulated cell-based gene therapy Encelto (revakinagene taroretcel-lwey) for a patient with idiopathic Macular Telangiectasia Type 2 (MacTel).

Posted: 8/12/2025

Keywords:

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Revakinagene Taroretcel-lwey

Up Next

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole

Stanislao Rizzo, MD

Pinhole Effect in Double Peel for Macular Hole

Pinhole Effect in Double Peel for Macular Hole

Hudson de Carvalho Nakamura, MD

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Triple Procedure With Chronic Macular Hole, Subluxated IOL, and Retinal Detachment

Frederic Aissani, MD

Macular Hole Surgery: Retinal Massager

Macular Hole Surgery: Retinal Massager

Manish Nagpal, MS, DO, FRCS(UK)

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Iatrogenic Macular Hole After TPA Injection for Submacular Hemorrhage

Frederic Aissani, MD

The Big Mac: ILM Technique for Large Macular Holes

The Big Mac: ILM Technique for Large Macular Holes

Hudson Nakamura, MD

ILM Peel for Macular Hole Under Liquid PFC

ILM Peel for Macular Hole Under Liquid PFC

Hudson Nakamura, MD

My Peeling Technique for a Dense Plaque on the Posterior Capsule

My Peeling Technique for a Dense Plaque on the Posterior Capsule

Ashraf Armia, FRCSG, FACS

Experience a New Dimension: How Eyetube3D Works!

Experience a New Dimension: How Eyetube3D Works!

25-Gauge Vitrectomy for Retained Lens Fragments

25-Gauge Vitrectomy for Retained Lens Fragments

Yoreh Barak, MD, Lana Rifkin, MD, Omar Saleh, MD, Shlomit Schaal, MD, PhD

Surgical Implantation of Revakinagene Taroretcel-lwey

Charles C. Wykoff, MD PhD

Charles C. Wykoff, MD, PhD, performs one of the first commercial procedures using encapsulated cell-based gene therapy Encelto (revakinagene taroretcel-lwey) for a patient with idiopathic Macular Telangiectasia Type 2 (MacTel).

Posted: 8/12/2025

Keywords:

Wet AMD

•

Age-Related Macular Degeneration (AMD)

•

Revakinagene Taroretcel-lwey

Please log in to leave a comment.

More in Retina

IL-6 Inhibition in Diabetic Macular Edema

IL-6 Inhibition in Diabetic Macular Edema

Arshad M. Khanani, MD, MA, FASRS, and Roger A. Goldberg, MD

Phase 3 Clinical Trial Results for OTX-TKI

Phase 3 Clinical Trial Results for OTX-TKI

Patricio G. Schlottmann, MD

Using OCT and AI to Evaluate Uveitis

Using OCT and AI to Evaluate Uveitis

Parisa Emami-Naeini, MD, MPH

Assessing SHRM With Faricimab Therapy

Assessing SHRM With Faricimab Therapy

SriniVas R. Sadda, MD